Merck KGaA (OTCMKTS:MKGAF) Sees Significant Growth in Short Interest

Merck KGaA (OTCMKTS:MKGAF) saw a significant increase in short interest during the month of February. As of February 28th, there was short interest totalling 555,200 shares, an increase of 27.9% from the February 13th total of 434,000 shares. Based on an average daily volume of 600 shares, the short-interest ratio is currently 925.3 days. Approximately 0.4% of the company’s stock are sold short.

Merck KGaA Stock Up 2.0 %

Shares of MKGAF stock traded up $2.94 on Monday, hitting $149.15. The stock had a trading volume of 780 shares, compared to its average volume of 788. The business has a 50 day moving average of $146.49 and a 200 day moving average of $157.56. The stock has a market cap of $19.28 billion, a price-to-earnings ratio of 22.77 and a beta of 0.96. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84. Merck KGaA has a 12-month low of $135.00 and a 12-month high of $200.56.

About Merck KGaA

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.